COOLSCULPTING SYSTEM
Report
- Report Number
- 3007215625-2021-01406
- Event Type
- Injury
- Date Received
- June 28, 2021
- Date of Event
- May 25, 2021
- Report Date
- June 11, 2024
- Manufacturer
- ALLERGAN PLEASANTON
- Product Code
- OOK
- PMA / PMN Number
- K160259
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
H11: CORRECTED DATA: SUBSEQUENT TO THE SUBMISSION OF INITIAL MEDWATCH, THIS REPORT HAS BEEN IDENTIFIED AS A DUPLICATE OF PREVIOUSLY SUBMITTED MEDWATCH REPORT OF 3007215625-2021-01406-00.
H11-: CORRECTED DATA: SUBSEQUENT TO THE SUBMISSION OF PREVIOUS MEDWATCH REPORT A CORRECTION WAS NOTED IN SECTION H10. CORRECTED STATEMENT IS THE FOLLOWING : SUBSEQUENT TO THE SUBMISSION OF INITIAL MEDWATCH, THIS REPORT HAS BEEN IDENTIFIED AS A DUPLICATE OF PREVIOUSLY SUBMITTED MEDWATCH REPORT OF 3007215625-2021-01389-00.
CORRECTION DATA: B5, D1, D4, G1, H6.
CASE IS DUPLICATE TO (B)(4). A TREATMENT PROVIDER REPORTED THEY HAVE A PATIENT WHO MAY HAVE DEVELOPED PARADOXICAL HYPERPLASIA POST COOLSCULPTING.
CASE IS DUPLICATE TO CASE (B)(4). A TREATMENT PROVIDER REPORTED THEY HAVE A PATIENT WHO MAY HAVE DEVELOPED PARADOXICAL HYPERPLASIA POST COOLSCULPTING.
THIS REPORT HAS BEEN IDENTIFIED AS A DUPLICATE OF PREVIOUSLY SUBMITTED MEDWATCH REPORT 3007215625-2021-01389-00.
THE FOLLOWING INFORMATION IS IN THE COOLSCULPTING USER MANUAL: PARADOXICAL HYPERPLASIA IS CHARACTERIZED BY A VISIBLY ENLARGED TISSUE VOLUME WITHIN THE TREATMENT AREA, WHICH MAY DEVELOP TWO TO FIVE MONTHS AFTER TREATMENT. SURGICAL INTERVENTION MAY BE REQUIRED. INVESTIGATION IS ONGOING.
ALLERGAN RECEIVED A REPORT OF A PATIENT WHO WAS TREATED WITH COOLSCULPTING AND MAY HAVE DEVELOPED PARADOXICAL HYPERPLASIA.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 975797 | COOLSCULPTING SYSTEM | DERMAL COOLING PACK/VACUUM/MASSAGER | OOK | ALLERGAN PLEASANTON | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female | Required Intervention |